Caprisa company information, Employees & Contact Information

Circulating immunoglobulins and transient lymphocytopenia in a sub-study of CAPRISA 012B, testing HIV monoclonal antibodies in a phase 1 trial | Scientific Reports Nature

Careers dedicated to science in service of humanity IAVI

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications | NEJM The New England Journal of Medicine

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women BMJ Open

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women Frontiers

Trump ends SA’s HIV and TB research grants Bhekisisa

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape ScienceDirect.com

HIV—No time for complacency Science | AAAS

A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis Frontiers

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition Nature

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth ScienceDirect.com

Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa Frontiers

Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women Nature

Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis Frontiers

The effect of interventions on the transmission and spread of HIV in South Africa: a phylodynamic analysis Nature

Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women Frontiers

Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth Frontiers

The gut and lung microbiome across the TB disease spectrum Frontiers

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV Frontiers

Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men Frontiers

New HIV drug taken twice a year shows promise in preventing infections in trials PBS

Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection Frontiers

Long COVID: a review and proposed visualization of the complexity of long COVID Frontiers

Metformin as Host-Directed Therapy for TB Treatment: Scoping Review Frontiers

HIV Prevention Clinical Trials Database avac.org

Journal of the International AIDS Society | IAS HIV Research Journal Wiley Online Library

High mortality among patients with tuberculosis accessing primary care facilities: secondary analysis from an open-label cluster-randomised trial The Lancet

Investigating the effects of cytokine biomarkers on HIV incidence: a case study for individuals randomized to pre-exposure prophylaxis vs. control Frontiers

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection The New England Journal of Medicine

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women The New England Journal of Medicine

Additive quantile mixed effects modelling with application to longitudinal CD4 count data Nature

HIV self-testing as part of a differentiated HIV testing approach: exploring urban and rural adult experiences from KwaZulu-Natal, South Africa using a cross-over study design BMC Public Health

CAPRISA designated a Centre of Excellence for HIV prevention UNAIDS

Quarraisha Abdool Karim Wins TWAS-Lenovo Prize Asia Research News |

Grand Challenges in Global Health: Community Engagement in Research in Developing Countries PLOS